Learn how KMA and LMA represent a breakthrough in treatment approaches for multiple myeloma and related disorders.

Creative Biolabs today announced the upgrade of its next-generation drug discovery pipeline with integrated AI-driven ...

The Monoclonal Antibodies Market has emerged as one of the most transformative sectors within the global biopharmaceutical ...

Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility Bispecific antibodies (bsAbs) have emerged as a novel ...

Focus shifted to development of first tri-specific antibody from the CAPTN-3 platform, IM1240, targeting 5T4 tumor-associated antigen, and second ...

Learn how BeSEC enables precise analysis of antibody aggregation and molecular weight through dual-angle light scattering.

The connection between multiple sclerosis and Epstein-Barr virus (EBV) is strengthening, according to a paper published this ...

Earlier-line bispecific therapy leverages lower disease refractoriness to drive deeper, more durable responses than typically ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

Objective A panel of antibodies against three antigens, University Hasselt (UH)-rheumatoid arthritis (RA).305, 318 and 329, ...

Epstein-Barr virus antibodies could help differentiate MS from MOGAD and NMOSD. Discover how this biomarker may improve ...

The connection between multiple sclerosis and Epstein-Barr virus (EBV) is strengthening, according to a paper published this ...